Objective: To evaluate our experience with percutaneous suprapubic cystolithotripsy (PCCL) in Yemeni children with endemic urinary bladder stones. Patients and Methods: Between January 1993 and December 1998, 117 children underwent percutaneous suprapubic lithotripsy in Arabia Felix Modern Hospital, Sana’a Republic of Yemen. The patients’ ages ranged from 8 months to 14 years (average 3.7 years). Ninety patients (77%) were under 5 years old; 20 patients (16%) were between 6 and 10 years old, and 7 patients (6%) were between 11 and 14 years old. There were 116 boys and 1 girl. The stone size ranged from 0.7 to 4 (average 2.3) cm. Five patients had coexisting urinary bilharziasis and another 5 patients had coexisting renal stone. In 10 patients, the stone was in the urethra. The procedure was done under general anesthesia. Dilation of the tract was made under fluoroscopy. The instrument was an adult 26–french nephroscope, the same as that used for percutaneous nephrolithotripsy. Ultrasound disintegration was needed for stones of >1 cm. A suprapubic catheter was left for 24 h, and a urethral catheter was kept for 48 h. Results: All patients became stone free. The average operating time was 15 (5–50) min. The average hospital stay was 2.7 (2–5) days. No severe intra– or postoperative complication was observed. The nucleus and/or the main component of the stones were ammonium acid urate in 109 patients (93%). Conclusion: Based on our experience we can conclude that percutaneous suprapubic lithotripsy is a safe and effective method for the treatment of bladder stones in children. It reduces morbidity and hospital stay and thus the cost of treatment. Our series proves the nutritional etiology of endemic pediatric bladder stones. To our knowledge, this is the largest series reported on percutaneous suprapubic management of endemic bladder stones in children.

1.
El–Khader K, Ibn–Attya A, Mamoun M, Koutani A, Hachimi M, Lakrissa A: Role of ultrasound lithotripsy in the treatment of lithiasis of the lower urinary tract. Apropos of 38 cases. J Urol Paris 1995;101:165–168.
2.
Agrawal MS, Aron M, Goyal J, Elhence IP, Asopa HS: Percutaneous suprapubic cystolithotripsy for vesical calculi in children. J Endourol 1999;13:173–175.
3.
El–Kapany H: Suprapubic percutaneous cystolitholapaxy in children. J Endourol 1992;6: 59–60.
4.
Hulbert JC: Percutaneous nephrolithotomy: An alternative approach to the management of pediatric calculus disease. Pediatrics 1985;76: 610.
5.
Bichler KH, Strohmaier WL, Korn S: Urolithiasis in childhood (in German). Monatsschr Kinderheilkd 1985;133:256–266.
6.
Carvajal–Busslinger MI, Gygi C, Ackermann D, Kaiser G, Bianchetti M: Urolithiasis in childhood: When to do what? Eur J Pediatr Surg 1994;4:199–200.
7.
Johnson O: Vesical calculus in Ethiopian children. Ethiop Med J 1995;33:31–35.
8.
Vanwaeyenbergh J, Vergauwe D, Verbeeck RM: Infrared spectrometric analysis of endemic bladder stones in Niger. Eur Urol 1995;27: 154–159.
9.
Kancha RK, Anasuya A: Contribution of vitamin A deficiency to calculogenic risk factors of urine: Studies in children. Biochem Med Metab Biol 1992;47:1–9.
10.
Drach GW: Urinary lithiasis: Etiology, diagnosis and medical management; in: Walsh PC, Retik AB, Stamey TA, Vaughan ED Jr (eds): Campbell’s Urology. Philadelphia, Saunders, 1998, pp 2720.
11.
Ikari O, Nettó NR Jr: D’Ancona CA, Plama PC: Percutaneous treatment of bladder stones. J Urol 1993;149:1499–1500.
12.
Wollin TA, Singal RK, Whelan T, Dicecco R, Razvi HA, Denstedt JD: Percutaneous suprapubic cystolithotripsy for treatment of large bladder calculi. J Endourol 1999;13:739–744.
13.
Shokeir AA: Transurethral cystolitholapaxy in children. J Endourol 1994;8:157–160.
14.
Mosbah A, Krid M, Baccouche S: Trans–urethral bladder lithotripsy using the Lithoclast in children. Apropos of 7 cases. Prog Urol 1995; 5:79–81.
15.
Husain I, El–Faqih SR, Shamsuddin AB, Atassi R: Primary extracorporeal shockwave lithotripsy in management of large bladder calculi. J Endourol 1994;8:183–186.
16.
Lin CM: Extracorporeal shock wave lithotripsy in children: Experience with the multifunctional lithotripter MFL 5000. Chung Hua Min Kuo Hsiao Erh Ko I Hsueh Hui Tsa Chih 1992; 33:357–362.
17.
Ni YH, Tsau YK, Chen CH, Hsu TC, Lee JD, Tsai WS: Urolithiasis in children. Chung Hua Min Kuo Hsiao Erh Ko I Hsueh Hui Tsa Chih 1991;32:9–16.
18.
Goel MC, Baserge NS, Babu RVR, Sinha S, Kapoor R: Pediatric kidney: Functional outcome after extracorporeal shock wave lithotripsy. J Urol 1996;155:2044.
19.
Losty P, Surana R, O’Donell B: Limitations of extracorporeal shock wave lithotripsy for urinary tract calculi in young children. J Pediatr Surg 1993;28:1037.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.